UMM logo
 Print this page
 Email this page

 Connect with UMMC on:
 Twitter
 Facebook
 YouTube
 iPhone

 Share this page:

Bookmark and Share

Transplant Center

Liver Transplant Program

Clinical Management

Evaluation Process

Each candidate will be seen by a multi-disciplinary group of consultants comprising the liver transplant screening committee. Each member of the consultant group interviews patients and offers suggestions from their unique perspective concerning any pre-transplant concerns or post-op management issues that may affect the outcome from liver transplantation.

These consultants include:

Additional consultants as indicated by medical condition or co-existing diseases include:

After the evaluation process is completed, the screening committee members will meet and review the cumulative data and render a decision as to the appropriateness and timing of liver transplantation for each patient. Decisions include:

A formal letter will be sent to each patient and the referring physician relaying the decision of the committee. If a patient is deferred, the patient and referring physician will be notified of the additional required data. If a patient is rejected, the reasons for rejection will be explained along with an offer to facilitate referral to another transplant center for additional consideration.

In addition to the consultant interviews, radiologic and laboratory investigations are performed to elucidate the cause and nature of their liver disease, assess functional capacity, determine patency of hepatic vascular supply, and to exclude co-existing medical conditions that would compromise patient or graft survival.

Some patients will require inpatient evaluation due to decompensated cirrhosis or acute hepatic failure. Their pre-transplant management and evaluation will be led by Transplant Hepatology. Patients may require therapeutic, as well as, diagnostic measures to improve their clinical and functional status. Patients with fulminant hepatic failure will require expedited evaluation and ongoing joint assessment by transplant hepatology and surgery as to the appropriateness and timing for transplantation.

Pre-Transplant Management

Patient Education

Pre-transplant patients are educated about and provided with information regarding:

Post-transplant patients are educated about and provided with information regarding:

Outpatient Post-Transplant Management

Patients are discharged from the hospital eight to fourteen days following liver transplantation. After initial discharge, until three months post-transplant, patients are seen in the transplant surgery clinic. After three months post-transplant, patients transition to the transplant hepatology clinic for continued management. The frequency of clinic visits in the transplant hepatology clinic are as follows:

Transplant hepatology clinic is designed to do a comprehensive review of laboratory data and diagnostic studies reflective of liver function, manage the immunosuppressive regimen that each patient is following, and monitor for recurrence of viral hepatitis. Each patient will be referred back to the primary care physician or gastroenterologist for routine health maintenance. As collaborative physical groups are caring for these patients, referral physicians should expect to regularly communicate with transplant center physicians and/or nurse coordinators. This communication is integral in formulating an overall plan of management for transplant recipients.

Routine Outpatient Laboratory Testing

Routine laboratory tests are necessary to monitor for the following: drug toxicity, graft rejection, infection secondary to immunosuppression, and the response of liver enzymes after treatment for graft rejection or after a change in the immunosuppressive regimen. Infection and graft rejection most often occur within six months following transplantation. In the event that one or both of these situations occurs, the frequency for laboratory testing will increase in order to closely monitor the patient's overall response. Our current protocol for laboratory testing is:

Routine laboratory tests include: CBC with differential, standard chemistries with a liver profile (ALT, AST, Alkaline Phosphatase, and bilirubin) and a Cyclosporin (Neoral) or FK506/Tacrolimus (Prograf) level. Patients can have laboratory testing done at Associates in Pathology Laboratory located at University of Maryland Hospital, at a preferred diagnostic center that is designated by a HMO, or at the referring physician's office.


This page was last updated on: September 2, 2008.

If you would like to make an appointment or talk to someone about our services, please call 410-328-5408 or 1-800-492-5538.